<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font29">the </span>
   <span class="font15">for </span>
   <span class="font15">with </span>
   <span class="font14">[]. </span>
   <span class="font14">peptide </span>
   <span class="font14">viral </span>
   <span class="font13">The </span>
   <span class="font13">virus </span>
   <span class="font13">from </span>
   <span class="font13">peptides </span>
   <span class="font13">that </span>
   <span class="font12">was </span>
   <span class="font12">protein </span>
   <span class="font12">influenza </span>
   <span class="font12">are </span>
   <span class="font12">against </span>
   <span class="font12">have </span>
   <span class="font11">hepatitis </span>
   <span class="font11">SARS-CoV- </span>
   <span class="font11">assay </span>
   <span class="font11">cell </span>
   <span class="font11">infection </span>
   <span class="font11">HIV- </span>
   <span class="font11">vaccine </span>
   <span class="font11">were </span>
   <span class="font11">Pre-clinical </span>
   <span class="font11">host </span>
   <span class="font11">antiviral </span>
   <span class="font11">derived </span>
   <span class="font11">fusion </span>
   <span class="font11">novel </span>
   <span class="font11">HIV </span>
   <span class="font11">its </span>
   <span class="font11">has </span>
   <span class="font11">peptide-based </span>
   <span class="font11">can </span>
   <span class="font11">shown </span>
   <span class="font11">using </span>
   <span class="font11">HBV </span>
   <span class="font11">been </span>
   <span class="font11">respiratory </span>
   <span class="font11">used </span>
   <span class="font11">{background </span>
   <span class="font11">binding </span>
   <span class="font11">vaccines </span>
   <span class="font11">human </span>
   <span class="font11">activity </span>
   <span class="font11">coronavirus </span>
   <span class="font11">potential </span>
   <span class="font11">[,]. </span>
   <span class="font11">inhibitor </span>
   <span class="font11">proteins </span>
   <span class="font10">SARS </span>
   <span class="font10">immune </span>
   <span class="font10">response </span>
   <span class="font10">their </span>
   <span class="font10">drug </span>
   <span class="font10">entry </span>
   <span class="font10">cells </span>
   <span class="font10">inhibitors </span>
   <span class="font10">margin </span>
   <span class="font10">acute </span>
   <span class="font10">antibodies </span>
   <span class="font10">efficacy </span>
   <span class="font10">patients </span>
   <span class="font10">receptor </span>
   <span class="font10">showed </span>
   <span class="font10">{border-style </span>
   <span class="font10">clinical </span>
   <span class="font10">high </span>
   <span class="font10">identified </span>
   <span class="font10">region </span>
   <span class="font10">disease </span>
   <span class="font10">px;} </span>
   <span class="font10">syndrome </span>
   <span class="font10">synthetic </span>
   <span class="font10">which </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">RNA </span>
   <span class="font10">also </span>
   <span class="font10">approved </span>
   <span class="font10">detection </span>
   <span class="font10">into </span>
   <span class="font10">potent </span>
   <span class="font10">pre-S </span>
   <span class="font10">severe </span>
   <span class="font10">[,,]. </span>
   <span class="font10">domain </span>
   <span class="font10">immunodeficiency </span>
   <span class="font10">such </span>
   <span class="font10">This </span>
   <span class="font10">development </span>
   <span class="font10">membrane </span>
   <span class="font10">two </span>
   <span class="font10">ACE </span>
   <span class="font10">Phase </span>
   <span class="font10">Rev. </span>
   <span class="font10">antibody </span>
   <span class="font10">epitopes </span>
   <span class="font10">inhibit </span>
   <span class="font10">targeting </span>
   <span class="font10">Sci. </span>
   <span class="font10">Virol. </span>
   <span class="font10">diagnostic </span>
   <span class="font10">inhibition </span>
   <span class="font10">prevent </span>
   <span class="font10">treatment </span>
   <span class="font10">vaccines, </span>
   <span class="font10">viruses </span>
   <span class="font10">â€" </span>
   <span class="font10">Influenza </span>
   <span class="font10">Peptide </span>
   <span class="font10">Peptides </span>
   <span class="font10">Res. </span>
   <span class="font10">Table </span>
   <span class="font10">Writing </span>
   <span class="font10">antigen </span>
   <span class="font10">based </span>
   <span class="font10">both </span>
   <span class="font10">chronic </span>
   <span class="font10">epitope </span>
   <span class="font10">induce </span>
   <span class="font10">infectious </span>
   <span class="font10">other </span>
   <span class="font10">phase </span>
   <span class="font10">protease </span>
   <span class="font10">recombinant </span>
   <span class="font10">study, </span>
   <span class="font10">Chem. </span>
   <span class="font10">FDA </span>
   <span class="font10">Microbiol. </span>
   <span class="font10">assays </span>
   <span class="font10">discovery </span>
   <span class="font10">diseases </span>
   <span class="font10">drugs </span>
   <span class="font10">effect </span>
   <span class="font10">highly </span>
   <span class="font10">interaction </span>
   <span class="font10">phage </span>
   <span class="font10">plaque </span>
   <span class="font10">replication </span>
   <span class="font10">specific </span>
   <span class="font10">through </span>
   <span class="font10">use </span>
   <span class="font10">Another </span>
   <span class="font10">CHB </span>
   <span class="font10">COVID- </span>
   <span class="font10">amino </span>
   <span class="font10">analysis </span>
   <span class="font10">caused </span>
   <span class="font10">current </span>
   <span class="font10">design </span>
   <span class="font10">designed </span>
   <span class="font10">due </span>
   <span class="font10">example </span>
   <span class="font10">library </span>
   <span class="font10">natural </span>
   <span class="font10">rapid </span>
   <span class="font10">reduction </span>
   <span class="font10">regions </span>
   <span class="font10">tested </span>
   <span class="font10">therapeutic </span>
   <span class="font10">this </span>
   <span class="font10">three </span>
   <span class="font10">vaccine, </span>
   <span class="font10">-residue </span>
   <span class="font10">Health </span>
   <span class="font10">Med. </span>
   <span class="font10">Onee </span>
   <span class="font10">acid </span>
   <span class="font10">approach </span>
   <span class="font10">identify </span>
   <span class="font10">infected </span>
   <span class="font10">inhibitory </span>
   <span class="font10">mice </span>
   <span class="font10">pandemic </span>
   <span class="font10">safety </span>
   <span class="font10">structural </span>
   <span class="font10">studies </span>
   <span class="font10">surface </span>
   <span class="font10">target </span>
   <span class="font10">than </span>
   <span class="font10">therapies </span>
   <span class="font10">trials </span>
   <span class="font10">However, </span>
   <span class="font10">Immunol. </span>
   <span class="font10">T-cell </span>
   <span class="font10">another </span>
   <span class="font10">anti-viral </span>
   <span class="font10">conserved </span>
   <span class="font10">emerging </span>
   <span class="font10">envelope </span>
   <span class="font10">further </span>
   <span class="font10">heptad </span>
   <span class="font10">include </span>
   <span class="font10">including </span>
   <span class="font10">long </span>
   <span class="font10">mRNA </span>
   <span class="font10">neutralizing </span>
   <span class="font10">px; </span>
   <span class="font10">repeat </span>
   <span class="font10">resistance </span>
   <span class="font10">results </span>
   <span class="font10">silico </span>
   <span class="font10">small </span>
   <span class="font10">strategies </span>
   <span class="font10">study </span>
   <span class="font10">targets </span>
   <span class="font10">type </span>
   <span class="font10">{font-family </span>
   <span class="font10">&amp;amp; </span>
   <span class="font10">(â€") </span>
   <span class="font10">Acids </span>
   <span class="font10">Biol. </span>
   <span class="font10">Cytopathic </span>
   <span class="font10">DNA </span>
   <span class="font10">III </span>
   <span class="font10">Infect. </span>
   <span class="font10">Mpro </span>
   <span class="font10">NHR </span>
   <span class="font10">NTCP </span>
   <span class="font10">approaches </span>
   <span class="font10">available </span>
   <span class="font10">binds </span>
   <span class="font10">block </span>
   <span class="font10">called </span>
   <span class="font10">cells. </span>
   <span class="font10">colleagues </span>
   <span class="font10">conformational </span>
   <span class="font10">develop </span>
   <span class="font10">developed </span>
   <span class="font10">during </span>
   <span class="font10">first </span>
   <span class="font10">font-size </span>
   <span class="font10">form </span>
   <span class="font10">four </span>
   <span class="font10">global </span>
   <span class="font10">infection. </span>
   <span class="font10">interact </span>
   <span class="font10">levels </span>
   <span class="font10">more </span>
   <span class="font10">not </span>
   <span class="font10">one </span>
   <span class="font10">original </span>
   <span class="font10">proteins, </span>
   <span class="font10">receptors </span>
   <span class="font10">release </span>
   <span class="font10">reported </span>
   <span class="font10">review </span>
   <span class="font10">spike </span>
   <span class="font10">stages </span>
   <span class="font10">structure </span>
   <span class="font10">subtypes </span>
   <span class="font10">suggested </span>
   <span class="font10">tests </span>
   <span class="font10">therapeutics </span>
   <span class="font10">therapy </span>
   <span class="font10">vitro </span>
   <span class="font10">(CPE)-based </span>
   <span class="font10">Acad. </span>
   <span class="font10">CHR </span>
   <span class="font10">ELISA </span>
   <span class="font10">HBsAg </span>
   <span class="font10">MDCK </span>
   <span class="font10">PLpro </span>
   <span class="font10">Peptide-based </span>
   <span class="font10">Rep. </span>
   <span class="font10">Server </span>
   <span class="font10">T-cells </span>
   <span class="font10">These </span>
   <span class="font10">Vaccine </span>
   <span class="font10">affinity </span>
   <span class="font10">anti-HIV </span>
   <span class="font10">applications </span>
   <span class="font10">combat </span>
   <span class="font10">could </span>
   <span class="font10">detected </span>
   <span class="font10">diagnosis </span>
   <span class="font10">different </span>
   <span class="font10">discussed </span>
   <span class="font10">display </span>
   <span class="font10">double; </span>
   <span class="font10">draft, </span>
   <span class="font10">editing. </span>
   <span class="font10">effective </span>
   <span class="font10">enhance </span>
   <span class="font10">enhanced </span>
   <span class="font10">failed </span>
   <span class="font10">fragments </span>
   <span class="font10">future </span>
   <span class="font10">had </span>
   <span class="font10">identification </span>
   <span class="font10">inhibited </span>
   <span class="font10">loops </span>
   <span class="font10">main </span>
   <span class="font10">over </span>
   <span class="font10">peptides, </span>
   <span class="font10">peptides. </span>
   <span class="font10">potency </span>
   <span class="font10">primary </span>
   <span class="font10">promising </span>
   <span class="font10">protective </span>
   <span class="font10">provide </span>
   <span class="font10">rate </span>
   <span class="font10">responses </span>
   <span class="font10">resulting </span>
   <span class="font10">reverse </span>
   <span class="font10">sequence </span>
   <span class="font10">similar </span>
   <span class="font10">some </span>
   <span class="font10">stability </span>
   <span class="font10">subunit </span>
   <span class="font10">these </span>
   <span class="font10">trial </span>
   <span class="font10">vivo </span>
   <span class="font10">when </span>
   <span class="font10">Î¼M </span>
   <span class="font10">Assay </span>
   <span class="font10">B-cell </span>
   <span class="font10">CCR </span>
   <span class="font10">COVID-. </span>
   <span class="font10">Commun. </span>
   <span class="font10">Despite </span>
   <span class="font10">Dis. </span>
   <span class="font10">Drug </span>
   <span class="font10">ELISA, </span>
   <span class="font10">Elsevier </span>
   <span class="font10">Engl. </span>
   <span class="font10">HA, </span>
   <span class="font10">HN, </span>
   <span class="font10">Kinetic </span>
   <span class="font10">Natl. </span>
   <span class="font10">Pharm. </span>
   <span class="font10">Res.Web </span>
   <span class="font10">acids </span>
   <span class="font10">antigenic </span>
   <span class="font10">antigens </span>
   <span class="font10">between </span>
   <span class="font10">bind </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">bound </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">candidates </span>
   <span class="font10">combination </span>
   <span class="font10">compared </span>
   <span class="font10">complex </span>
   <span class="font10">core </span>
   <span class="font10">detect </span>
   <span class="font10">determined </span>
   <span class="font10">early </span>
   <span class="font10">effects </span>
   <span class="font10">employed </span>
   <span class="font10">expression </span>
   <span class="font10">few </span>
   <span class="font10">five </span>
   <span class="font10">fragment </span>
   <span class="font10">genome </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">half-life </span>
   <span class="font10">improved </span>
   <span class="font10">induced </span>
   <span class="font10">inhibitor, </span>
   <span class="font10">inhibits </span>
   <span class="font10">issueWW </span>
   <span class="font10">key </span>
   <span class="font10">million </span>
   <span class="font10">minimal </span>
   <span class="font10">molecular </span>
   <span class="font10">most </span>
   <span class="font10">multiple </span>
   <span class="font10">new </span>
   <span class="font10">nucleocapsid </span>
   <span class="font10">only </span>
   <span class="font10">optimized </span>
   <span class="font10">overview </span>
   <span class="font10">polymerase </span>
   <span class="font10">prediction </span>
   <span class="font10">presence </span>
   <span class="font10">reduced </span>
   <span class="font10">result, </span>
   <span class="font10">resulted </span>
   <span class="font10">ribavirin </span>
   <span class="font10">samples </span>
   <span class="font10">sialic </span>
   <span class="font10">significant </span>
   <span class="font10">site </span>
   <span class="font10">solid; </span>
   <span class="font10">specificity </span>
   <span class="font10">strategy </span>
   <span class="font10">structures </span>
   <span class="font10">targeted </span>
   <span class="font10">therapies, </span>
   <span class="font10">variable </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(IC) </span>
   <span class="font10">(phase </span>
   <span class="font10">-fold </span>
   <span class="font10">-mer </span>
   <span class="font10">.â€¯Î¼M </span>
   <span class="font10">.â€¯Î¼g </span>
   <span class="font10">/mL, </span>
   <span class="font10">AIDS </span>
   <span class="font10">AIDS, </span>
   <span class="font10">Agents </span>
   <span class="font10">Biophys. </span>
   <span class="font10">C-terminal </span>
   <span class="font10">Chemother. </span>
   <span class="font10">China </span>
   <span class="font10">Derived </span>
   <span class="font10">Due </span>
   <span class="font10">Format </span>
   <span class="font10">Hepatol. </span>
   <span class="font10">Int. </span>
   <span class="font10">LL- </span>
   <span class="font10">N-terminal </span>
   <span class="font10">Name </span>
   <span class="font10">Neutralization </span>
   <span class="font10">Reference </span>
   <span class="font10">SARS-CoV-, </span>
   <span class="font10">SARS-CoV-. </span>
   <span class="font10">Sequence </span>
   <span class="font10">Severe </span>
   <span class="font10">Sâˆ’ </span>
   <span class="font10">Target </span>
   <span class="font10">Tested </span>
   <span class="font10">Ther. </span>
   <span class="font10">Two </span>
   <span class="font10">VAX </span>
   <span class="font10">VIR </span>
   <span class="font10">acid-mimic </span>
   <span class="font10">activities </span>
   <span class="font10">activity. </span>
   <span class="font10">addition </span>
   <span class="font10">addition, </span>
   <span class="font10">additional </span>
   <span class="font10">administration </span>
   <span class="font10">advantages </span>
   <span class="font10">after </span>
   <span class="font10">agents </span>
   <span class="font10">al. </span>
   <span class="font10">allows </span>
   <span class="font10">analogs </span>
   <span class="font10">animal </span>
   <span class="font10">antimicrobial </span>
   <span class="font10">associated </span>
   <span class="font10">attachment </span>
   <span class="font10">authors </span>
   <span class="font10">bioinformatic </span>
   <span class="font10">blocks </span>
   <span class="font10">bold </span>
   <span class="font10">candidate </span>
   <span class="font10">cellular </span>
   <span class="font10">centre </span>
   <span class="font10">change </span>
   <span class="font10">changes </span>
   <span class="font10">chemokine </span>
   <span class="font10">combinatorial </span>
   <span class="font10">composed </span>
   <span class="font10">comprised </span>
   <span class="font10">concentration </span>
   <span class="font10">considered </span>
   <span class="font10">corresponding </span>
   <span class="font10">courier; </span>
   <span class="font10">critical </span>
   <span class="font10">currently </span>
   <span class="font10">delivery </span>
   <span class="font10">developing </span>
   <span class="font10">drugs. </span>
   <span class="font10">each </span>
   <span class="font10">efforts </span>
   <span class="font10">em; </span>
   <span class="font10">endosomal </span>
   <span class="font10">enzyme </span>
   <span class="font10">example, </span>
   <span class="font10">extracellular </span>
   <span class="font10">family </span>
   <span class="font10">generated </span>
   <span class="font10">genetic </span>
   <span class="font10">great </span>
   <span class="font10">growth </span>
   <span class="font10">helical </span>
   <span class="font10">immunized </span>
   <span class="font10">immunogenicity </span>
   <span class="font10">increased </span>
   <span class="font10">inducing </span>
   <span class="font10">inhibitors, </span>
   <span class="font10">large </span>
   <span class="font10">less </span>
   <span class="font10">linear </span>
   <span class="font10">linked </span>
   <span class="font10">liver </span>
   <span class="font10">loop </span>
   <span class="font10">low </span>
   <span class="font10">major </span>
   <span class="font10">maturation </span>
   <span class="font10">might </span>
   <span class="font10">models </span>
   <span class="font10">multi-epitope </span>
   <span class="font10">n/a </span>
   <span class="font10">naturally </span>
   <span class="font10">need </span>
   <span class="font10">next. </span>
   <span class="font10">octapeptide </span>
   <span class="font10">particles </span>
   <span class="font10">peptide, </span>
   <span class="font10">picomolar </span>
   <span class="font10">polypeptide </span>
   <span class="font10">positive </span>
   <span class="font10">pre-clinical </span>
   <span class="font10">prevention </span>
   <span class="font10">proteases </span>
   <span class="font10">protein, </span>
   <span class="font10">provided </span>
   <span class="font10">provides </span>
   <span class="font10">pt;} </span>
   <span class="font10">range </span>
   <span class="font10">residues </span>
   <span class="font10">resource </span>
   <span class="font10">role </span>
   <span class="font10">selected </span>
   <span class="font10">sensitive </span>
   <span class="font10">separate </span>
   <span class="font10">sera </span>
   <span class="font10">server </span>
   <span class="font10">shock </span>
   <span class="font10">skin </span>
   <span class="font10">substrate </span>
   <span class="font10">suggesting </span>
   <span class="font10">summarized </span>
   <span class="font10">synthesis </span>
   <span class="font10">test </span>
   <span class="font10">then </span>
   <span class="font10">therapies. </span>
   <span class="font10">tools </span>
   <span class="font10">types </span>
   <span class="font10">utilized </span>
   <span class="font10">various </span>
   <span class="font10">years </span>
   <span class="font10">Î²-defensin- </span>
  </p>
 </body>
</html>
